Cyclobenzaprine hydrochloride

CAS No. 6202-23-9

Cyclobenzaprine hydrochloride( Flexeril | Lisseril | MK-130 )

Catalog No. M15348 CAS No. 6202-23-9

Cyclobenzaprine hydrochloride is a muscle relaxant by blocking pain sensations, used for the treatment of muscle spasms.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 46 In Stock
1G 81 In Stock

Biological Information

  • Product Name
    Cyclobenzaprine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyclobenzaprine hydrochloride is a muscle relaxant by blocking pain sensations, used for the treatment of muscle spasms.
  • Description
    Cyclobenzaprine hydrochloride is a muscle relaxant by blocking pain sensations, used for the treatment of muscle spasms.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Flexeril | Lisseril | MK-130
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    6202-23-9
  • Formula Weight
    311.86
  • Molecular Formula
    C20H22ClN
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 62 mg/mL (198.81 mM); Water: 62 mg/mL (198.81 mM); DMSO: 62 mg/mL (198.81 mM)
  • SMILES
    Cl.CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Honda M, et al. Eur J Pharmacol. 2003 Jan 1;458(1-2):91-9.
molnova catalog
related products
  • AVN-101 hydrochlorid...

    AVN-101 is a very potent 5-HT7 receptor antagonist (Ki = 153 pM). AVN-101 also exhibits a rather high affinity toward histamine H1 (Ki = 0.58 nM) and adrenergic α2A, α2B, and α2C (Ki = 0.41-3.6 nM) receptors.

  • Mosapride Citrate

    Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.

  • Gamabufotalin

    Gamabufotalin, a major bufadienolide of Chansu, has been used for treatment of COX-2-mediated diseases and cancer therapy due to its desirable metabolic stability and less adverse effect.